[Treatment of acute respiratory infections in childhood with a new cephalosporin, ceftriaxone].
Results of the comparison between tobramicine and ceftriaxone (new long-acting 3rd generation cephalosporin) in the treatment of pediatric acute respiratory tract infections are referred. Treatment with ceftriaxone is judged more advantageous both for efficacy and for saving the number of administered doses.
D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002443:Ceftriaxone; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014031:Tobramycin / Q000627:therapeutic use
D002443:Ceftriaxone; D002439:Cefotaxime; D014031:Tobramycin
Trattamento delle infezioni acute respiratorie in età pediatrica con una nuova cefalosporina, il ceftriaxone.